PEPTIDOMIMETISCHE MAKROZYKLEN

European patent · EP2822572 · In force

Register entry

Publication number
EP2822572
Application number
EP13748983
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Feb 14, 2013
Published
Jan 14, 2015
Granted
Jun 10, 2020
Protection ends at the latest
Feb 13, 2033
Next annual fee due
Feb 28, 2027
IPC classes
A61K 38/12 (2006.01)
Priority
US 201261599328 P 15.02.2012
US 201261656962 P 07.06.2012
US 201261723770 P 07.11.2012
PCT application
PCT/US2013/026238 14.02.2013
PCT publication
WO2013/123266 22.08.2013
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Mar 27, 2026

    Change

    Published in Swissreg on 27.03.2026

  2. Mar 4, 2025

    Change

    Published in Swissreg on 04.03.2025

  3. Jul 30, 2024

    Change

    Published in Swissreg on 30.07.2024

  4. Mar 6, 2023

    Change

    Published in Swissreg on 06.03.2023

  5. Oct 30, 2020

    Address changed

    Owner
    Aileron Therapeutics, Inc., 281 Albany Street, Cambridge, MA 02139, USA → Aileron Therapeutics, Inc., 490 Arsenal Way, Watertown, MA 02472, USA

    Published in Swissreg on 30.10.2020

  6. Oct 29, 2020

    Address changed

    Published in Swissreg on 29.10.2020

  7. Jun 10, 2020

    Granted

    Published in Swissreg on 10.06.2020

Parties

Inventor

SAWYER, Tomi, K.

Southborough, MA 01772, US

FEYFANT, Eric

Lexington, MA 02421, US

ELKIN, Carl

Arlington, MA 02476, US

GRAVES, Bradford, J.

Nutley, NJ 07110, US

NASH, Huw, M.

Lexington, MA 02421, US

GUERLAVAIS, Vincent

Arlington, MA 02476, US

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.